文献速递神经核医学肿瘤 PET/CT

18F-FDG、11C-蛋氨酸与18F-FET PET用于胶质瘤分级的荟萃分析

Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
PubMed 文献 · Clin Nucl Med · 2019-01-01

MET和FET的汇总灵敏度显著高于FDG(分别为94%、88%和63%,P < 0.001),而FDG的汇总特异度显著高于MET和FET(分别为89%、55%和57%,P = 0.002)。FDG的阳性似然比高于FET和MET。结论认为MET和FET在识别胶质瘤分级方面灵敏度优于FDG。

要点

  • MET和FET PET对胶质瘤分级的灵敏度显著高于FDG PET。
  • FDG PET的特异度显著高于MET和FET PET。
  • FDG的阳性似然比高于FET和MET。

核心结论

  • MET和FET在识别胶质瘤分级的灵敏度方面优于FDG。

主要发现

  • MET、FET和FDG的汇总灵敏度分别为94%、88%和63%,MET与FET均显著高于FDG(P < 0.001)。
  • FDG、MET和FET的汇总特异度分别为89%、55%和57%,FDG显著高于MET和FET(P = 0.002)。
  • FDG的阳性似然比高于FET和MET。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Gliomas constitute the most frequent primary brain tumors. Glioblastoma, the most common and malignant glioma in adults, has dismal prognosis with any current therapy. On the other hand, low-grade gliomas, the second most common type of gliomas, are potentially curative with appropriate treatment. METHODS: We conducted a meta-analysis to assess the performance of PET tracers with the best available evidence, namely, fluorodeoxyglucose (FDG), C-methionine (MET), and F-fluoroethyltyrosine (FET), in differentiating low- from high-grade gliomas. RESULTS: Twenty-three studies with a total of 994 participants were included in this meta-analysis. The pooled sensitivities of both MET PET and FET PET were found to be significantly higher than of FDG PET (94%, 88%, and 63% respectively, P < 0.001). The pooled specificity of FDG PET was found to be significantly greater compared with both MET PET and FET PET (89%, 55%, and 57%, respectively; P = 0.002). Fluorodeoxyglucose PET was superior in terms of higher positive likelihood ratio values compared with both FET PET and MET PET. CONCLUSIONS: This meta-analysis indicated that both MET and FET were superior to FDG in terms of sensitivity for identifying glioma grade.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Katsanos AH, Alexiou GA, Fotopoulos AD, et al. Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis. Clin Nucl Med. 2019. PMID: 31205150. doi:10.1097/RLU.0000000000002654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。